Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Case Reports

Research Support, N.I.H., Extramural

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Multicenter Study

Clinical Trial, Phase III

Systematic Review

Clinical Trial, Phase II

Letter

Observational Study

Publication Year

From

Quick links

Individual year

2024

2023

2021

2020

2019

2017

2011

2007

2005

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Desmoid Tumors""[mesh_terms]

19 Results

Searching titles within these results

PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis.

Mitchell C Posner, Narasimhan P Agaram, Julian M Rozenberg, Mrinal M Gounder, Aimee M Crago, Samuel Singer, Nicholas D Socci, Jia Hu, Li-Xuan Qin, Meera R Hameed, Karissa A Whiting, Anthony M Villano, Rachael B O'Connor, Sonia Cohen, Katherine Prendergast, Sara Kryeziu, Richard L White

Clinical cancer research : an official journal of the American Association for Cancer Research 2024;30(2):450-461

Free Full Text

Abstract

Pancreatic desmoid-type fibromatosis with beta-catenin gene mutation-Report of a case and review of the literature.

Yoshitane Tsukamoto, Masami Imakita, Akiko Nishitani, Toshikazu Ito, Masaaki Izukura, Seiichi Hirota

Pathology, research and practice 2017;212(5):484-9

Full Text

Abstract

Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.

S Tsukamoto, T Takahama, A F Mavrogenis, Y Tanaka, Y Tanaka, C Errani

Musculoskeletal surgery 2023;107(1):7-18

Full Text

Abstract

Active surveillance and emerging medical treatment options for desmoid: when and for whom?

Sylvie Bonvalot, Bernd Kasper, Aisha Miah

Current opinion in oncology 2024;36(4):263-268

Full Text

Abstract

Desmoid Fibromatosis: Management in an Era of Increasing Options.

Ravin Ratan, Christina L Roland, Andrew J Bishop

Current oncology reports 2021;23(4):41

Full Text

Abstract

A cost analysis of sorafenib for desmoid tumors.

Michael S Johns, William T Merritt, Lori Rhodes, Candice N Ford, Mark Thompson, William M Lee, Yarrow Sheldon, Nicholas J Petrelli, Gregory J Tiesi

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2023;29(3):663-668

Full Text

Abstract

Examining nirogacestat for adults with progressing desmoid tumors who require systemic treatment.

Bernd Kasper, Fernando Campos

Expert opinion on pharmacotherapy 2024;25(16):2115-2124

Full Text

Abstract

Current management of familial adenomatous polyposis.

Stefano Signoroni, Maria Teresa Ricci, Marco Vitellaro, Chiara Colombo, Elena Palassini, Federica Cavalcoli, Patrizia Pasanisi, Emanuele Rausa, Sara Lauricella, Ilaria Pellegrini

Expert review of anticancer therapy 2024;24(6):363-377

Full Text

Abstract

Aggressive fibromatosis of the neck treated with a combination of chemotherapy and indomethacin.

Alessandra Longhi, Costantino Errani, Milva Battaglia, Marco Alberghini, Stefano Ferrari, Mario Mercuri, Massimo Molinari

Ear, nose, & throat journal 2011;90(6):E11-5

Free Full Text

Abstract

Combined administration of ethodolac, ascorbic acid and radiotherapy as adjuvant therapies in an extrathoracic desmoid tumor with gross postoperative residual disease; case report and review of the literature.

S Kilçiksiz, T Gökçe, I Somali, A Duransoy, A Aydin, S Yiğit

Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2007;11(3):355-8

Full Text

Abstract

Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene.

Chiara Balducci, Cinzia Lilli, Giordano Stabellini, Lorella Marinucci, Giammario Giustozzi, Alessio Becchetti, Lucio Cagini, Paola Locci

BMC cancer 2005;5():22

Free Full Text

Abstract

Sorafenib for Advanced and Refractory Desmoid Tumors.

Mrinal M Gounder, Michelle R Mahoney, Brian A Van Tine, Vinod Ravi, Steven Attia, Hari A Deshpande, Abha A Gupta, Mohammed M Milhem, Robert M Conry, Sujana Movva, Michael J Pishvaian, Richard F Riedel, Tarek Sabagh, William D Tap, Natally Horvat, Ethan Basch, Lawrence H Schwartz, Robert G Maki, Narasimhan P Agaram, Robert A Lefkowitz, Yousef Mazaheri, Rikiya Yamashita, John J Wright, Amylou C Dueck, Gary K Schwartz

The New England journal of medicine 2019;379(25):2417-2428

Free Full Text

Abstract

Desmoid tumours stalled by sorafenib.

Katharine H Wrighton

Nature reviews. Clinical oncology 2019;16(4):209

Full Text

Emerging Role of Multikinase Inhibitors in Desmoid Tumor Management.

Nicolas Penel, Thomas Ryckewaert, Marie-Cécile Le Deley

American journal of clinical oncology 2020;42(12):958

Full Text

Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose.

Vikas Garg, Bharath B Gangadharaiah, Sameer Rastogi, Ashish Upadhyay, Adarsh Barwad, Ekta Dhamija, Shivanand Gamangatti

European journal of cancer (Oxford, England : 1990) 2023;186():142-150

Full Text

Abstract

Results: 1 – 15 / 19

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Desmoid Tumors""[mesh_terms]

PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis.

Pancreatic desmoid-type fibromatosis with beta-catenin gene mutation-Report of a case and review of the literature.

Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.

Active surveillance and emerging medical treatment options for desmoid: when and for whom?

Desmoid Fibromatosis: Management in an Era of Increasing Options.

A cost analysis of sorafenib for desmoid tumors.

Examining nirogacestat for adults with progressing desmoid tumors who require systemic treatment.

Current management of familial adenomatous polyposis.

Aggressive fibromatosis of the neck treated with a combination of chemotherapy and indomethacin.

Combined administration of ethodolac, ascorbic acid and radiotherapy as adjuvant therapies in an extrathoracic desmoid tumor with gross postoperative residual disease; case report and review of the literature.

Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene.

Sorafenib for Advanced and Refractory Desmoid Tumors.

Desmoid tumours stalled by sorafenib.

Emerging Role of Multikinase Inhibitors in Desmoid Tumor Management.

Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose.

Results for
""Desmoid Tumors""[mesh_terms]